Sign Up for FORCE Newsletters

IMPROVING THE LIVES OF INDIVIDUALS AND FAMILIES FACING HEREDITARY CANCER.

Attend our FREE virtual conference for the hereditary cancer community.

October 12-13, 2022


Get more information and

Register Now

National Hereditary Cancer Week 2022

We recognize and honor all those affected by hereditary cancer during this special awareness week. Join us in raising life-saving awareness.

Can you tell what online health information is trustworthy?

Our interactive tool and quiz will show you how to spot unreliable health information.

FORCE improves the lives of the millions of individuals and families facing hereditary cancer.

We accomplish this through our education, support, advocacy and research efforts.

September 15, 2022

National Hereditary Cancer Week 2022

National Hereditary Cancer Week (NHCW) and National Previvor Day are opportunities to shine the light on hereditary cancer, impart knowledge and save lives. Add your voice to our #1FORCECommunity, so we can make a difference together! This year,...

PARP inhibitor treatment for metastatic prostate cancer shows most benefit in men with inherited BRCA mutations

Featured XRAY

PARP inhibitor treatment for metastatic prostate cancer shows most benefit in men with inherited BRCA mutations

This study looked at the benefit of using the PARP inhibitor niraparib to treat metastatic castration-resistant prostate cancer (mCRPC). Participants included those with an inherited or tumor mutation in BRCA1 or BRCA2 or an inherited...
Survey about Endometrial Cancer Risk and Risk-Reducing Surgery for Women with a BRCA1/2 Mutation or Mutation in the Family

Featured Research

Survey about Endometrial Cancer Risk and Risk-Reducing Surgery for Women with a BRCA1/2 Mutation or Mutation in the Family

Researchers at the Mayo Clinic, McGill University and FORCE are conducting a survey of women with a BRCA1/2 mutation, or who come from a family with a known BRCA mutation but tested negative, or have...

Meet Our Community

Our impact is best shared through the stories of our growing community. Read about the survivors and previvors facing hereditary breast, colorectal, endometrial, ovarian, pancreatic and prostate cancers as a result of a BRCA, ATM, PALB2, CHEK2, PTEN or other inherited gene mutation and those with Lynch syndrome. We are comprised of many mutations and many cancers but we are one community!